Zobrazeno 1 - 10
of 42
pro vyhledávání: '"S. W. Zimmerman"'
Autor:
Y-J, Yi, S W, Zimmerman, G, Manandhar, J F, Odhiambo, C, Kennedy, V, Jonáková, P, Maňásková-Postlerová, M, Sutovsky, C-S, Park, P, Sutovsky
Publikováno v:
International journal of andrology. 35(2)
Protein ubiquitination is a stable, covalent post-translational modification that alters protein activity and/or targets proteins for proteolysis by the 26S proteasome. The E1-type ubiquitin-activating enzyme (UBA1) is responsible for ubiquitin activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::416964aa847d533761dd4619b282f3b5
https://pubmed.ncbi.nlm.nih.gov/21950462
https://pubmed.ncbi.nlm.nih.gov/21950462
Autor:
C A, Johnson, M, Wakeen, C A, Taylor, S W, Zimmerman, J, Burkart, A, Bhattacharya, M R, Kosorok
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 19(6)
To compare the efficacy of intraperitoneal (i.p.) and subcutaneous (s.c.) administration of epoetin alfa in patients receiving peritoneal dialysis (PD).A 32-week prospective, randomized, cross-over experimental design.Two university-based outpatient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::558e4975f59a9c55d3e095f37ea952dc
https://pubmed.ncbi.nlm.nih.gov/10641779
https://pubmed.ncbi.nlm.nih.gov/10641779
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 17(2)
Long-term experience of patients on peritoneal dialysis (PD) in general, and in diabetic patients specifically, is limited. Few patients have been followed on PD for over 8 years. Our aim was to evaluate and characterize long-term survivors (LTS) on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::60286b7f3754e10c250a78f97f037252
https://pubmed.ncbi.nlm.nih.gov/9159835
https://pubmed.ncbi.nlm.nih.gov/9159835
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 16(1)
Data from the United States Renal Data Systems (USRDS) suggest that older diabetic patients with end-stage renal disease will have improved survival if they receive hemodialysis versus peritoneal dialysis. Younger diabetic patients have equal surviva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c23c2dbc6db5d96493af0f297553a895
https://pubmed.ncbi.nlm.nih.gov/8616176
https://pubmed.ncbi.nlm.nih.gov/8616176
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 15(2)
Part I: To evaluate the long-term effects of daily glucose absorption from the peritoneal dialysis fluid on the formation of low-molecular-weight advanced glycosylation end-products (AGE-peptides) in nondiabetic continuous ambulatory peritoneal dialy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ec21362d094a645d0b09e00f9bb0cf7d
https://pubmed.ncbi.nlm.nih.gov/7612732
https://pubmed.ncbi.nlm.nih.gov/7612732
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 14(2)
To identify factors associated with peritoneal dialysis-related infections at one center.The study was a retrospective study of a 3-year time period with relatively stable treatment patterns.A single center experienced academic peritoneal dialysis pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::54a84518ac70cc2c77353d50f62c8368
https://pubmed.ncbi.nlm.nih.gov/8043666
https://pubmed.ncbi.nlm.nih.gov/8043666
Publikováno v:
Clinical pharmacy. 12(8)
The effect of peritonitis on plasma and dialysate alpha 1-acid glycoprotein (AAG) concentrations was determined. Plasma and dialysate samples were obtained at the onset of infection and one month after treatment from 10 peritoneal dialysis patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d83fe0cb38d4b63ead21d538f976c9cd
https://pubmed.ncbi.nlm.nih.gov/8222525
https://pubmed.ncbi.nlm.nih.gov/8222525
Publikováno v:
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 8
Iron supplementation is usually required in patients receiving epoetin alfa. Ferrous sulfate is commonly prescribed, however many patients experience adverse gastrointestinal effects. Adverse effects may limit the amount of iron that can be prescribe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c666c04bc33acd77a607765cb031094e
https://pubmed.ncbi.nlm.nih.gov/1361844
https://pubmed.ncbi.nlm.nih.gov/1361844
Autor:
S W, Zimmerman, C A, Johnson
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 18(4 Suppl 1)
Erythropoietin (Epo) is currently used less extensively in peritoneal dialysis (PD) patients than in hemodialysis (HD) patients. Early data suggest that Epo is equally effective in PD patients, and that the risk profile is similar. No adverse consequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c93fe4edbda84aae0a183b0f6f927505
https://pubmed.ncbi.nlm.nih.gov/1928078
https://pubmed.ncbi.nlm.nih.gov/1928078
Autor:
F. Wiedenhoeft, Craig Wa, S. W. Zimmerman, C. A. Johnson, M. O’Brien, J E Leggett, J. Feyzi, E. Ahrens
Publikováno v:
Ambulatory Peritoneal Dialysis ISBN: 9781461595571
Peritoneal dialysis (PD) is a growing alternative to hemodialysis. Despite major technological advances, peritonitis and catheter exit-site infections remain significant causes of morbidity and eventual failure of this dialysis modality.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bef6029c4e5c6be714c741e986780928
https://doi.org/10.1007/978-1-4615-9555-7_45
https://doi.org/10.1007/978-1-4615-9555-7_45
